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BACKGROUND: There is a prevalence increase of overweight and obesity in Indonesia. Central obesity can lead a variety of chronic diseases 
through the inflammatory process. There are some markers 
for low-grade chronic inflammatory, such as cathepsin S, 
high sensitivity C-reactive protein (hs-CRP), interleukin-1-
beta (IL-1β). To our current interest that central obesity can 
lead to various chronic diseases through the inflammatory 
process, we conducted a study to investigate correlation of 
Cathepsin S, hs-CRP, IL-1β in men with central obesity.
METHODS: A cross-sectional study was conducted. 
Seventy-eight selected subjects were examined to collect 
anthropometric data and prepared for sample collection. 
Collected samples were processed for the following 
biochemical analyses: fasting glucose, high density 
lipoprotein (HDL)-cholesterol, triglyceride, serum glutamic 
oxaloacetic transaminase (SGOT), serum glutamate 
pyruvate transaminase (SGPT), cathepsin S, hs-CRP, and 
IL-1β. Data distribution and variable correlation were then 
statistically analyzed.
RESULTS: There were significant correlations between 
waist circumference (WC) and cathepsin S (p=0.030; 
r=0.214), hs-CRP and cathepsin S (p=0.007; r=0.276), 
triglyceride and IL-1β (p=0.019; r=-0.235), WC and systolic 
blood pressure (SBP) (p=0.003; r=-0.312), WC and fasting 
glucose (p=0.000; r=0.380), WC and body mass index 
(BMI) (p=0.000; r=0.708).
CONCLUSION: Our study showed that cathepsin S was 
correlated with central obesity, suggesting that cathepsin S 
LATAR BELAKANG: Prevalensi kelebihan berat badan dan obesitas semakin meningkat di Indonesia. Obesitas sentral dapat menimbulkan 
berbagai penyakit kronik melalui proses inflamasi. Terdapat 
beberapa penanda inflamasi kronik derajat rendah, seperti 
cathepsin S, high sensitivity C-reactive protein (hs-CRP), 
interleukin-1-beta (IL-1β). Terkait ketertarikan kami 
pada saat ini mengenai obesitas yang dapat menyebabkan 
berbagai penyakit kronik, maka kami melakukan studi 
untuk mengetahui korelasi cathepsin S, hs-CRP, IL-1β pada 
pria dengan obesitas sentral.
METODE: Penelitian ini menggunakan metode potong 
lintang.  Tujuh puluh delapan subyek dilakukan pemeriksaan 
untuk mendapatkan data antropometrik dan persiapan 
pengumpulan sampel. Sampel kemudian diproses dan 
dilakukan analisa biokimia sebagai berikut: glukosa puasa, 
high density lipoprotein (HDL) kolesterol, trigliserida, 
serum glutamic oxaloacetic transaminase (SGOT), serum 
glutamate pyruvate transaminase (SGPT), cathepsin S, 
hs-CRP, dan IL-1β. Kemudian, dilakukan analisa statistik 
terhadap distribusi data dan korelasi variabel.
HASIL: Didapatkan hasil korelasi bermakna antara lingkar 
pinggang (LP) dan cathepsin S (p=0,030; r=0,214), hs-
CRP dan cathepsin S (p=0,007; r=0,276), trigliserida dan 
IL-1β (p=0,019; r=-0,235), LP dan tekanan darah sistolik 
(p=0,003; r=-0,312), LP dan glukosa puasa (p=0,000; 
r=0,380), LP and indeks berat badan (p=0,000; r=0,708).
KESIMPULAN: Penelitian ini memperlihatkan bahwa 
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Currently, there is an increase in the prevalence of 
overweight and obesity in the whole world as a negative 
consequence of increasing economic development in Asia-
Pacific countries. The World Health Organization estimates 
that 1 billion people overweight and 300 million are defined 
as obese. Based on Indonesia Family Life Survey conducted 
in population of 20,593 individuals in the year of 2000, the 
prevalence of obesity (body mass index (BMI) ≥30 kg/m2) 
in Indonesia was around 1.3% in male and 4.5% in female. 
National prevalence of general obesity for population over 
the age of 15 in Indonesia was estimated at 19.1% (8.8% 
overweight and 10.3% obese) where as in specific the 
prevalence of central obesity was 18.8%. Indonesia national 
obesity prevalence is higher in female (23.8%) than male 
(13.9%). Based on province, the highest prevalence of 
central obesity was North Sulawesi (31.5%), followed by 
Gorontalo (27%) and Jakarta (27.9%), respectively.(1) 
Prevalence increase of central obesity has an impact on 
the emergence of various degenerative diseases. Central 
obesity is associated with increased metabolic syndrome(2), 
atherosclerosis(3), cardiovascular disease(4,5), diabetes type 
2(6,7), gallstones(8), impaired of pulmonary function(9), 
hypertension and dyslipidemia(10).
 Adipokine plays an important role in the regulation of 
local and systemic metabolism, which indicate the presence 
of endocrine activity. Therefore, not only as a repository of fat 
but adipose tissue is an active endocrine organ that secretes 
various adipokines, which triggers inflammatory changes in 
the liver, systemic inflammation and atherosclerosis.(11,12) 
Several studies show obesity is also associated with low-
grade chronic inflammatory conditions in adipose tissue, 
which was characterized by infiltration of macrophages 
and inflammatory gene expression. Weight loss in obese 
subjects may reduce pro-inflammatory molecules, thereby 
improving inflammatory status.(13)
 Cathepsin S was reported to be reduced along 
with the weight loss.(14) Cathepsin S mRNA and serum 
were reported to have positive correlation with BMI and 
decreased after gastric surgery and weight loss. It has been 
could be a potential inflammatory marker in central obesity 
in the future.
KEYWORDS: obesity, inflammation, hs-CRP, cathepsin S, 
IL-1β, waist circumference
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cathepsin S berkorelasi bermakna dengan obesitas sentral, 
sehingga cathepsin S dapat diusulkan sebagai salah satu 
penanda inflamasi pada obesitas sentral yang berpotensi di 
masa yang akan datang.
KATA KUNCI: obesitas, Inflamasi, hs-CRP, cathepsin S, 
IL-1β, lingkar pinggang
shown previously, in cell culture experiment, each cathepsin 
S, L or K suppressed the ability of humans to differentiate 
pre-adipocyte by blocking the degradation of extracellular 
fibronectin. Cell culture studies in animals showed that this 
protease increased adipogenesis and glucose hemostasis 
effect. Cathepsin L, S, and K are found in human adipose 
tissue with different expression patterns.(15)
 Smooth muscle cells could synthesize human coronary 
arteries C-reactive protein (CRP) due to stimulation of 
inflammatory cytokines. Under stimulation of inflammatory 
cytokines, adipocyte could produce CRP. Induction may be 
increase due to the presence of interleukin (IL)-1β and IL-6. 
IL-1β genes control the expression of acute phase proteins 
through activation of the transcription factors: signal 
transducer and activator of transcription 3 (STAT3) and 
nuclear factor kB (NF-kB).(16) IL-1β is a pro-inflammatory 
cytokine involved in pain, inflammation and autoimmune 
conditions(17), produced mainly by myeloid cells(18). 
Cathepsin S may be regulated, expressed and induced by 
cytokines IL-1β, interferon gamma (IFN-γ) and tumor 
necrosis factor-α (TNF-α).(19)
 To our current interest that central obesity can lead 
to various chronic diseases through the inflammatory 
process, we conducted a study to investigate correlation 
of inflammatory markers such as cathepsin S, IL-1β, high 
sensitivity CRP (hs-CRP) in men with central obesity.
Introduction
Methods
Study Design and Subject Selection
A cross-sectional study was conducted at Prodia Clinical 
Laboratory in Manado and Jakarta. The study protocol 
was approved by the Health Research Ethics Committee 
of the Faculty of Medicine Hasanuddin University (no.
UH13030111). All written informed consents were 
collected accordingly. Initially, subjects, in the age of 30-60 
years, completed a questionnaire related to medical history, 
exercise, medicine intake, smoking habit and alcohol 
intake. Men with central obesity was determined based on 
International Diabetes Federation 2005 criteria, that waist 
circumference (WC) ≥90 cm.
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Sample Collection
All subjects were examined after an overnight fasting for 10-
12 hours. Measurement of anthropometric parameters (WC 
≥90 cm, height, weight, blood pressure) and biochemical 
variable as follows: concentration of fasting glucose, high 
density lipoprotein (HDL)-cholesterol, triglyceride, serum 
glutamic oxaloacetic transaminase (SGOT), serum glutamate 
pyruvate transaminase (SGPT), hs-CRP, cathepsin S and IL-
1β. Fasting serum samples were obtained and kept at -200C. 
Subjects with hs-CRP ≥10 mg/L or  SGOT/SGPT more than 
5 times normal value, were excluded.
Biochemical Analysis
HDL cholesterol and triglyceride were measured with 
homogeneus enzymatic method. Fasting plasma glucose 
was measured with hexokinase method. SGOT and SGPT 
were measured with the International Federation of Clinical 
Chemistry method without pyridoxal phospate activation. 
All of above methods were performed by using Cobas 
501 (Roche Diagnostics, Mannheim, Germany) in Prodia 
Laboratory, Manado. Level of hs-CRP was measured with 
immunoturbidimetric method using Cobas Integra (Roche 
Diagnostics). For detection of Cathepsin S, Human Total 
Cathepsin S ELISA Kit (Aviscera Bioscience, Santa Clara, 
CA) was used. For IL-1β detection, Human IL-1 beta/IL-1F2 
Quantikine HS ELISA Kit (R&D Systems, Minneapolis, 
MN) was used. ELISA was performed using Microplate 
Reader 680 series (Bio-Rad Laboratories, Hercules, CA) 
in Prodia Laboratory Jakarta. All assays were performed 
according to kit manuals.
Statistical Analysis 
Statistical analysis was conducted using IBM SPSS for 
Windows version 19.0 (IBM Corp., Armonk, NY). Normality 
of continuous variable distribution was analyzed with 
Kolmogorov-Smirnov test. Meanwhile variable correlation 
was analyzed with Spearman correlation analysis.  p-value 
of ≤0.05 was considered as statistically significant.
Characteristics Mean±SD    Median Min Max Range
    Age (year) 46.33±7.88 48.00 30.00 60.00 31.00
    WC (cm) 102.40±7.58   102.00 91.00 130.00 39.00
    Weight (kg) 80.91±12.59   78.05 58.00 118.40 60.40
    Height (cm) 166.66±7.93 166.00 145.00 185.00 40.00
    BMI  (kg/m2) 30.34±4.61   29.38 21.83 44.56 22.73
    DBP (mmHg) 8282±7.50 80.00 70.00 105.00 35.00
    SBP (mmHg) 122.50±10.53 120.00 105.00 170.00 65.00
Table 1. Anthropometric characteristics
DBP: diastolic blood pressure; SBP: systolic blood pressure; Min: minimum; Max: maximum
Table 2. Biochemical characteristics
Characteristics Mean±CV Median Min Max Range
     SGOT (U/L) 27.18±11.09 24.00 11.00 76.00 65.00
     SGPT (U/L) 41.27±26.12 34.00 9.00 140.00 131.00
     Fasting Glucose (mg/dL) 108.96±6.07 99.00 79.00 298.00 219.00
     HDL-C (mg/dL) 42.00±8.18 40.00 31.00 68.00 37.00
     Triglyceride (mg/dL) 159.35±9.17 138.50 58.00 433.00 375.00
     hs-CRP (mg/L) 2.85±2.34 2.10 0.30 9.80 9.50
     Cathepsin S (pg/mL) 9.34±0.23 9.33 8.68 9.85 1.16
     IL-1β (pg/mL) 10.31±21.08 0.42 0.04 57.00 56.96
Min: minimum; Max: maximum
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Table 3. Data distribution
Characteristics
Kolmogorov-
Smirnov Z p -value
     Age 0.853 0.461
     WC 0.959 0.317
     Weight 1.015 0.255
     Height 0.619 0.837
     BMI 0.941 0.339
     DBP 2.427 0.000
     SBP 2.187 0.000
     SGOT 1.642 0.000
     SGPT 1.592 0.013
     Fasting Glucose 2.534 0.000
     HDL-C 1.306 0.066
     Triglyceride 0.729 0.005
     hs-CRP 1.503 0.022
     Cathepsin S 0.606 0.856
     IL-1β 3.804 0.000
Discussion
of bias, since some studies suggested that concentration of 
hs-CRP were influenced by gender.(20,21) 
 Previous studies showed that local IL-1β in adipocytes 
and hepatocytes contributed to accumulation of fatty liver 
in obesity. Weight loss caused decreased expression of IL-
1β in the subcutaneous fat and liver.(22) However, in our 
current study, we did not find significant correlation of WC 
with IL-1β. We suggest a large subject number with bigger 
WC differences to be studied in order to confirm our current 
result.
 In our study, WC was significantly correlated with 
cathepsin S, This supports some reports that suggest men 
with WC ≥90 cm linked to low and chronic inflammatory 
process, which is characterized by a positive correlation to 
the inflammatory markers.(23,24) Cathepsin S was reported 
by Taleb, et al., to have strong correlation with BMI at the 
mean of 50 kg/m2.(25) Since in our study, only a maximum 
of 30.34 kg/m2 BMI, less bulky than the subjects in  Taleb 
study, therefore we found weak correlation between BMI 
and cathepsin S. Our results showed that WC is more related 
to the risk of metabolic disorders and cardiovascular disease 
than BMI which pertaining to peripheral obesity.(26)
 We found a significant correlation between hs-CRP 
with cathepsin S, which is in accordance to a report showing 
the interplay between the activity of cathepsin S with hs-
CRP and IL-6 even in normal individuals.(21) However, 
no significant correlation was found between IL-1β and 
cathepsin S, suggesting that the developing inflammatory 
allegedly through other mechanisms. Other pathways on the 
expression of cathepsin S, such as IL-1 receptor antagonist, 
produced by subcutaneous white adipose tissue, can bind to 
the IL-1 receptor to compete pro-inflammatory IL-1 (α and 
β).(27,28) Further study is needed to investigate underlying 
mechanism of cathepsin S in men with central obesity.
Conclusion
Our study result showed significant correlation between 
Cathepsin S and central obesity. Cathepsin S could be a 
potential as inflammation marker in central obesity. Further 
study is needed to determine underlying mechanism of 
Cathepsin S in men with central obesity.
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Results
This study was conducted from April to May 2012. Seventy-
eight subjects were selected. Anthropometric characteristics 
were shown in Table 1. Meanwhile biochemical 
characteristics were shown in Table 2, and normality of 
continuous variable distribution were shown in Table 3.
 Based on Spearman correlation analysis, significant 
correlated biochemical characteristics were WC with 
cathepsin S, hs-CRP with cathepsin S, triglyceride with IL-
1β, WC with SBP, WC with fasting glucose, and WC with 
BMI (Table 4).
Our study was conducted to investigate the relationship 
between central obesity with inflammation, represented by 
IL-1β, cathepsin S and hs-CRP as markers of inflammation. 
Only men were included in this study to prevent possibility 
 119
Cathepsin S was Correlated with Waist Circumference (Todingrante A)Indones  Biomed J.  2013; 5(2): 115-20DOI: 10.18585/inabj.v5i2.60
Table 4.  Correlation of  parameters
Parameter hs-CRP Cathepsin S IL-1β
Correlation (r) 1.000 0.153 0.214 0.107
Significant (p) - 0.091 0.030* 0.176
Correlation (r) 0.153 1.000 0.276 0.126
Significant (p) 0.091 - 0.007** 0.137
Correlation (r) 0.214 0.276 1.000 0.040
Significant (p) 0.030* 0.007** - 0.363
Correlation (r) 0.107 0.126 0.040 1.000
Significant (p) 0.176 0.137 0.363 -
Correlation (r) -0.085 -0.076 0.075 0.012
Significant (p) 0,230 0.255 0.256 0.460
Correlation (r) 0.108 0.031 0.146 -0.235
Significant (p) 0.174 0.393 0.100 0.019*
Correlation (r) 0.312 -0.114 0.175 -0.042
Significant (p) 0.003** 0.160 0.062 0.358
Correlation (r) 0.129 -0.018 0.154 -0.066
Significant (p) 0.130 0.439 0.089 0.284
Correlation (r) 0.380 -0.044 0.046 0.120
Significant (p) 0.000** 0.351 0.344 0.149
Correlation (r) 0.708** 0.195 0.162 0.148
Significant (p) 0.000 0.087 0.157 0.196
     HDL
                            WC
     WC
     hs-CRP
     Cathepsin  S
     IL-1β
     Triglyceride
     SBP
     DBP
     Fasting glucose
     BMI
*correlation at significant level of p≤0.05; **correlation at significant level of p≤0.01
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